Cargando…
Comparison of efficacy and safety of three novel hypoglycemic agents in patients with severe diabetic kidney disease: A systematic review and network meta-analysis of randomized controlled trials
OBJECTIVE: To analyze the efficacy and safety of three novel hypoglycemic agents, glucagon-like peptidyl-1 receptor agonists, dipeptidyl peptidase-4 inhibitors (DPP-4i), and sodium-glucose cotransporter two inhibitors (SGLT2i) in type 2 diabetes mellitus (T2DM) patients with severe chronic kidney di...
Autores principales: | Li, Yijun, Hu, Ying, Huyan, Xiaoyuan, Chen, Kang, Li, Bing, Gu, Weijun, Mu, Yiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637657/ https://www.ncbi.nlm.nih.gov/pubmed/36353233 http://dx.doi.org/10.3389/fendo.2022.1003263 |
Ejemplares similares
-
Efficacy and Safety of Eldecalcitol for Osteoporosis: A Meta-Analysis of Randomized Controlled Trials
por: Liu, Hongyan, et al.
Publicado: (2022) -
Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes: A Network Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021) -
Case Report: Three Rare Cases of Ectopic ACTH Syndrome Caused by Adrenal Medullary Hyperplasia
por: Cheng, Yu, et al.
Publicado: (2021) -
Analysis of characteristics of four patients with adrenal unicentric Castleman disease
por: Yu, Hao, et al.
Publicado: (2023) -
Predictors of consciousness improvement in patients with hypoglycemic encephalopathy
por: Lee, Yu Eun, et al.
Publicado: (2022)